Bikle Daniel D
Department of Medicine and Endocrine Research Unit, Veterans Affairs Medical Center and University of California, San Francisco, California.
J Endocr Soc. 2020 Feb 8;4(2):bvz038. doi: 10.1210/jendso/bvz038. eCollection 2020 Feb 1.
The interest in vitamin D continues unabated with thousands of publications contributing to a vast and growing literature each year. It is widely recognized that the vitamin D receptor (VDR) and the enzymes that metabolize vitamin D are found in many cells, not just those involved with calcium and phosphate homeostasis. In this mini review I have focused primarily on recent studies that provide new insights into vitamin D metabolism, mechanisms of action, and clinical applications. In particular, I examine how mutations in vitamin D metabolizing enzymes-and new information on their regulation-links vitamin D metabolism into areas such as metabolism and diseases outside that of the musculoskeletal system. New information regarding the mechanisms governing the function of the VDR elucidates how this molecule can be so multifunctional in a cell-specific fashion. Clinically, the difficulty in determining vitamin D sufficiency for all groups is addressed, including a discussion of whether the standard measure of vitamin D sufficiency, total 25OHD (25 hydroxyvitamin) levels, may not be the best measure-at least by itself. Finally, several recent large clinical trials exploring the role of vitamin D supplementation in nonskeletal diseases are briefly reviewed, with an eye toward what questions they answered and what new questions they raised.
人们对维生素D的兴趣持续不减,每年都有成千上万的出版物为浩如烟海且不断增长的文献做出贡献。人们普遍认识到,维生素D受体(VDR)以及代谢维生素D的酶存在于许多细胞中,而不仅仅是参与钙和磷稳态的细胞。在这篇小型综述中,我主要关注了近期的研究,这些研究为维生素D的代谢、作用机制及临床应用提供了新的见解。特别是,我研究了维生素D代谢酶的突变以及它们调控的新信息如何将维生素D代谢与肌肉骨骼系统之外的代谢和疾病等领域联系起来。关于VDR功能调控机制的新信息阐明了该分子如何以细胞特异性方式具有如此多的功能。在临床上,讨论了确定所有人群维生素D充足性的困难,包括探讨维生素D充足性的标准衡量指标——总25OHD(25羟维生素)水平是否并非最佳衡量指标——至少单独使用时并非如此。最后,简要回顾了近期几项探索维生素D补充剂在非骨骼疾病中作用的大型临床试验,关注它们回答了哪些问题以及提出了哪些新问题。